Glucotrack completes reverse merger with Lokahi; existing holders get 10% floor

Glucotrack, Inc.

Lokahi shareholders receive 90% of fully diluted equity; existing Glucotrack holders get at least 10%.
CEO Paul Goode resigns; Erik Emerson appointed CEO and board member effective July 14, 2026.
Bridge financing of $4.45M via senior secured convertible notes and warrants closed same day.
Subsidiary contribution of $7M to Operating Sub for diabetes business, released in installments.
Post-closing: proxy statement for stockholder approval and Nasdaq listing of conversion shares.

item 1.01 item 2.01 item 2.03 item 3.02 item 5.01 item 5.02 item 5.03 item 7.01 item 8.01 item 9.01

Featured in Daily 8-K Digest

Selected #4 for 2026-07-15. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.